Results

Total Results: 1,571 records

Showing results for "discussed".

181. Disposition of Comments for CER 160 Binge Eating Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating-disposition-160504.pdf
     December 09, 2015 - We have also now more explicitly discussed the IPT results and highlighted their sustainability over … IPT and DBT are discussed earlier in the chapter. … As discussed in this review, I am extremely concerned that the conclusions from this report cannot be

182. Disposition of comments_Comparative Effectiveness Review No. 244: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-of-vaccines.pdf
     May 25, 2021 - Peer Reviewer #2 General Second, individual vaccines are discussed in separate sections throughout … clearly explicated in the report, and likely pose some methodologic limitations that should be clearly discussed … We appreciate this suggestion and discussed it. … Another limitation that could have been discussed in more detail is that all immunizations may not … detail; however, the basis of the relative risk (including individual study contributions) is fully discussed

183. 13-MDM347013 30..38 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
     January 01, 2009 - Patient Outcome After Testing: The Big Picture Figure 2 summarizes all of the effects discussed so far … useful, health-related quality-of-life measures rarely capture all the possible effects of testing discussed … For evaluating some of the emotional, social, cognitive, and behavioral effects discussed earlier, more

184. 13-MDM347013 30..38 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
     January 01, 2009 - Patient Outcome After Testing: The Big Picture Figure 2 summarizes all of the effects discussed so far … useful, health-related quality-of-life measures rarely capture all the possible effects of testing discussed … For evaluating some of the emotional, social, cognitive, and behavioral effects discussed earlier, more

185. Innovations in Stakeholder Engagement Conference Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/innovations_in_stakeholder_engagement_conference_summary2.pdf
     October 01, 2011 - These are discussed in the next section.

186. Disposition of Comments for Strategies To Prevent Weight Gain Among Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_disposition-comments.pdf
     March 25, 2013 - The subgroups were discussed with the Key Informants and Technical Expert Panel. … Team discussed terminology to be applied were relevant throughout report. … As discussed above (see Introduction), the outcome (long-term weight gain) and relevant interventions … In considering the utility and applicability of this report, the bar for “high” evidence should be discussed … Peer reviewer 6 Introduction Given that these topics were discussed in later sections of the report

187. Disposition of Comments for CER 167 Renal Masses (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
     February 24, 2016 - This is discussed in Research Gaps, KQ1. … A problem we face with this literature and discussed in the report is that numerous studies do not … perhaps state a statistically significant association, regardless of the magnitude of difference) are discussed … The main issue is that of verification bias. if you believe this should be discussed here, also consider … A problem we face with this literature and discussed in the report is that numerous studies do not

188. Disposition of Comments for Progestogens for Prevention of Preterm Birth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
     September 07, 2012 - With regard to safety we have updated the report as discussed above. … This matter needs to be considered and discussed. See tables 4 through 16 for examples. … the Meis trial meaning that analyses that build from the same population are noted, counted and discussed … And, if 2 other trials (one fair, one good) are included in the analysis (as discussed on page 42), … considered by some to be a symptom of preterm labor, she inquired whether the Fonseca 2007 trial can be discussed

189. Disposition of Comments_Comparative Effectiveness Review No. 274: Diagnosis and Treatment of Tethered Spinal Cord (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-274-tethered-spinal-cord-disposition-comments.pdf
     October 25, 2024 - Disposition of Comments_Comparative Effectiveness Review No. 274: Diagnosis and Treatment of Tethered Spinal Cord Comparative Effectiveness Review Disposition of Comments Report Title: Diagnosis and Treatment of Tethered Spinal Cord Draft report available for public comment from February 23, 2024, to…

190. Disposition of Comments for Quality Improvement Interventions To Address Health Disparities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
     August 27, 2012 - KEY QUESTIONS: They seem reasonable, however, I don’t see that they necessarily imply the approach discussed … Table 2 is a very helpful distillation of the inclusion criteria as discussed in the Analytic Framework … This should be discussed in the text as well as in the appropriate appendix. … I know we discussed how we were defining "health outcomes" during one of the TEP meetings. … I know this point is discussed later in the report (e.g. pg ES-5 lines 7-32) but it needs to be underscored

191. Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_disposition-comments.pdf
     July 03, 2012 - Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1171 Published Online: July 3, 2012 Comparative Effectiveness Research Review Disposition of Comme…

192. Disposition of Comments for CER 164 Home-Based Primary Care Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/home-based-care_disposition-comments.pdf
     February 16, 2016 - Costs of the intervention are not discussed -- perhaps they are not reported by the research.

193. Disposition of Comments CER 219 Antipsychotics for the Prevention and Treatment of Delirium (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/delirium-disposition-comments.pdf
     September 03, 2019 - Synthesis section that outcome definition was a key variable for determining homogeneity and that we had discussed

194. Disposition of Comments: Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-disposition-comments.pdf
     August 20, 2024 - Disposition of Comments: Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review Comparative Effectiveness Review Disposition of Comments Report Title: Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review Draft…

195. Disposition of Comments for Diagnostic Accuracy of Screening and Treatment of Post-Acute Coronary Syndrome Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-200-comments-post-acs.pdf
     November 14, 2017 - there is little evidence for the benefit of depression screening) should be acknowledged and briefly discussed

196. Disposition of Comments for Imaging Tests for the Staging of Colorectal Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
     November 20, 2014 - Results: The results are presented appropriately, with the caveats discussed above. … Heterogeneity was not discussed in the text. … Statistical heterogeneity was discussed in the text for analyses where it was detected. … Heterogeneity of the imaging protocols was also discussed, and meta-regressions were performed with … Two major limitations: assumption of reference standard and evidence base was discussed.

197. Disposition of Comments Report for Treatment for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
     November 27, 2012 - Regarding harms of therapy, these are discussed in detail in KQ 3, including risk of severe rash (we … As will be discussed below, the abstract states that boceprevir is associated with increased risk of … We discussed this with KI, TEP and AHRQ MO, and they affirmed this decision, we limited the review to … We discussed this with KI, TEP and AHRQ MO, and they affirmed this decision.” … We discussed this with KI, TEP and AHRQ MO, and they affirmed this decision Genentech, Public Reviewer

198. Disposition of Comments Report for Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
     July 08, 2014 - report is to compare pharmacologic treatments to each other and to other treatments such as those discussed … Only issue as discussed above in that comparators to pharmacologic therapy include ‘any’ non-pharmacologic … The evidence is discussed in the full report later, but would add to the results on ES-12, line 33 … The evidence discussed here is insufficient to support conclusions because it is based on a single very

199. Dispostion of Comments Report for Child and Adolescent Exposure to Trauma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
     February 11, 2013 - is merited and may suggest the need to review data from observational studies not yet included (as discussed … We have discussed some of these issues in our “Research Gaps” section.

200. Disposition of Comments for Pressure Ulcer Treatment Strategies: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_disposition-comments.pdf
     May 08, 2013 - Given the nursing time that is required (which requires FTE), it should be discussed. … For example, the PUSH tool scale should be described, and its validity discussed. … My specific observations on the 5 included studies are discussed below: 1) Allman 1987: rated as ' … Applicability is considered separately and discussed in the text. … Significant design and reporting errors are discussed in the review paper– please read Clark 2008